Novel CAR-T therapy shows promising safety and durable responses in hard-to-treat multiple myeloma

In vivo CAR-T therapy: From customized living drugs to universal genetic medicines

Efficacy and safety of semaglutide according to frailty status

Identification of broadly tumour-reactive γδ TCRs from multiple myeloma